Format

Send to

Choose Destination
Arch Pharm Res. 2009 Aug;32(8):1103-8. doi: 10.1007/s12272-009-1801-1. Epub 2009 Aug 29.

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases.

Author information

1
Department of General Pathology and Excellence Research Center on Cardiovascular Diseases, University of Naples, Italy. claudio.napoli@unina2.it

Abstract

Nitric oxide (NO) is a pivotal signaling messenger in the cardiovascular system. NO participates in regulatory functions including control of hemostasis, fibrinolysis, platelet and leukocyte interactions with the arterial wall, regulation of vascular tone, proliferation of vascular smooth muscle cells, and homeostasis of blood pressure. Diminished NO bioavailability and abnormalities in NO-dependent signaling are among central factors of vascular disease, although it is unclear whether this is a cause of, or result of endothelial dysfunction or both pathogenic events. Disturbances in NO bioavailability have been linked to cause endothelial dysfunction, leading to increased susceptibility to atherosclerotic lesion progression, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis and stroke.

PMID:
19727602
DOI:
10.1007/s12272-009-1801-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center